NO156036C - Fremgangsmaate for fremstilling av et frysetoerket beta-laktamantibiotikumpreparat som er stabilt overfor misfarging og kjemisk nedbryting - Google Patents

Fremgangsmaate for fremstilling av et frysetoerket beta-laktamantibiotikumpreparat som er stabilt overfor misfarging og kjemisk nedbryting

Info

Publication number
NO156036C
NO156036C NO812090A NO812090A NO156036C NO 156036 C NO156036 C NO 156036C NO 812090 A NO812090 A NO 812090A NO 812090 A NO812090 A NO 812090A NO 156036 C NO156036 C NO 156036C
Authority
NO
Norway
Prior art keywords
miscellaneous
freeze
procedure
preparation
lactam antibiotic
Prior art date
Application number
NO812090A
Other languages
English (en)
Other versions
NO812090L (no
NO156036B (no
Inventor
Eizo Hirai
Kazuhiro Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO812090L publication Critical patent/NO812090L/no
Publication of NO156036B publication Critical patent/NO156036B/no
Publication of NO156036C publication Critical patent/NO156036C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
NO812090A 1980-06-23 1981-06-19 Fremgangsmaate for fremstilling av et frysetoerket beta-laktamantibiotikumpreparat som er stabilt overfor misfarging og kjemisk nedbryting NO156036C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (3)

Publication Number Publication Date
NO812090L NO812090L (no) 1981-12-28
NO156036B NO156036B (no) 1987-04-06
NO156036C true NO156036C (no) 1987-07-15

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812090A NO156036C (no) 1980-06-23 1981-06-19 Fremgangsmaate for fremstilling av et frysetoerket beta-laktamantibiotikumpreparat som er stabilt overfor misfarging og kjemisk nedbryting

Country Status (31)

Country Link
US (1) US4418058A (no)
JP (1) JPS5711909A (no)
KR (1) KR840000693B1 (no)
AR (1) AR230007A1 (no)
AT (1) AT380790B (no)
AU (1) AU541627B2 (no)
BE (1) BE889351A (no)
BG (1) BG37991A3 (no)
CA (1) CA1164801A (no)
CH (1) CH648210A5 (no)
CS (1) CS221835B2 (no)
DD (1) DD159879A5 (no)
DE (1) DE3124592A1 (no)
DK (1) DK158443C (no)
ES (1) ES503283A0 (no)
FI (1) FI75490C (no)
FR (1) FR2484835A1 (no)
GB (1) GB2078737B (no)
GR (1) GR75646B (no)
HU (1) HU183494B (no)
IE (1) IE51331B1 (no)
IL (1) IL63136A (no)
IT (1) IT1144812B (no)
NL (1) NL191777C (no)
NO (1) NO156036C (no)
NZ (1) NZ197414A (no)
PT (1) PT73239B (no)
RO (1) RO82720B (no)
SE (1) SE460702B (no)
YU (1) YU44416B (no)
ZA (1) ZA814203B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
BR0112417A (pt) * 2000-07-13 2003-07-01 Daiichi Seiyaku Co Composições farmacêuticas contendo composto dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (no) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
FR2374031A1 (fr) * 1976-12-17 1978-07-13 Scherico Ltd Nouvelles formulations d'antibiotiques b-lactame, leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
RO82720A (ro) 1984-05-23
SE460702B (sv) 1989-11-13
DK274981A (da) 1981-12-24
BE889351A (fr) 1981-10-16
ES8203887A1 (es) 1982-04-01
YU44416B (en) 1990-08-31
SE8103904L (sv) 1981-12-24
IT8167863A0 (it) 1981-06-22
YU157381A (en) 1984-10-31
KR830005848A (ko) 1983-09-14
JPS6364405B2 (no) 1988-12-12
GR75646B (no) 1984-08-02
CS221835B2 (en) 1983-04-29
DE3124592C2 (no) 1990-12-20
DD159879A5 (de) 1983-04-13
ES503283A0 (es) 1982-04-01
US4418058A (en) 1983-11-29
IL63136A (en) 1984-07-31
NL191777B (nl) 1996-04-01
FI75490B (fi) 1988-03-31
JPS5711909A (en) 1982-01-21
CH648210A5 (de) 1985-03-15
CA1164801A (en) 1984-04-03
PT73239A (en) 1981-07-01
AR230007A1 (es) 1984-02-29
GB2078737A (en) 1982-01-13
FR2484835B1 (no) 1983-07-01
DK158443B (da) 1990-05-21
FI811948L (fi) 1981-12-24
NZ197414A (en) 1984-10-19
NO812090L (no) 1981-12-28
FI75490C (fi) 1988-07-11
NL8102943A (nl) 1982-01-18
RO82720B (ro) 1984-07-30
IL63136A0 (en) 1981-09-13
IE51331B1 (en) 1986-12-10
AU541627B2 (en) 1985-01-17
AU7209781A (en) 1983-01-06
DE3124592A1 (de) 1982-02-11
KR840000693B1 (ko) 1984-05-21
IT1144812B (it) 1986-10-29
PT73239B (en) 1982-07-22
GB2078737B (en) 1984-03-14
DK158443C (da) 1990-10-08
ZA814203B (en) 1982-09-29
AT380790B (de) 1986-07-10
NO156036B (no) 1987-04-06
ATA278881A (de) 1985-12-15
NL191777C (nl) 1996-08-02
HU183494B (en) 1984-05-28
IE811347L (en) 1981-12-23
BG37991A3 (en) 1985-09-16
FR2484835A1 (fr) 1981-12-24

Similar Documents

Publication Publication Date Title
DE2961979D1 (en) Novel naphtyridine derivatives and pharmaceutical compositions containing them
JPS56125362A (en) Beta lactam antibiotic and manufacture
JPS55143978A (en) Trimerization of diisocyanate
PT73826B (en) Process for the preparation of bicyclooxyphenyl ureas and of pesticidal compositions containing them
NO850007L (no) Antibiotisk forbindelse og fremgangsmaate til fremstilling av forbindelsen og blandinger inneholdende forbindelsen
RO85264A (ro) Procedeu pentru prepararea unor derivati ai triazolinei
EP0349649A4 (en) Abnormality detector of injection apparatus
IL58579A0 (en) Nitrogen heterocyclic compounds their preparation and pharmaceutical compositions containing them
NO156036C (no) Fremgangsmaate for fremstilling av et frysetoerket beta-laktamantibiotikumpreparat som er stabilt overfor misfarging og kjemisk nedbryting
NZ189213A (en) 2-pyrrolidone derivatives and processes using them
NO802836L (no) Analogifremgangsmaate for fremstilling av beta-laktamantibiotika
AU553440B2 (en) Composition containing a 6beta-halopenicillin and a beta lactam antibiotic
JPS557285A (en) Lactam compound and medical composition
ZA81889B (en) 3-q-demethyl derivatives of sannamycin c and antibiotic ax-127b-1
JPS5621597A (en) Recovery of aminoglycoside antibiotic substance
IL54328A (en) Substituted pyrido(2,1-b)quinazoline-11-one derivatives,their manufacture and pharmaceutical compositions containing them
DE2862196D1 (en) Pyrrolo(2,1-b)(3)benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them
NO820898L (no) Fremgangsmaate og mellomprodukt for fremstilling av 1,1-dioksopenicillanoyl-oksymetyl-6-(2-amino-2-fenyl-acetamido)penicillanat antibiotika
DE3063395D1 (en) Halogenated beta-lactam compounds and process for their preparation
GB2021558B (en) Antibiotic substance mycoplanecin
PT80123A (en) Process for preparing novel antibiotics and pharmaceutical compositions containing them useful for treatin protozoal infections
PT82970A (en) Process for preparing heterocyclic compounds and of pesticide compositions containing the same
JPS5610184A (en) Pyridine derivatives and medicinal composition containing them
JPS54135777A (en) Novel tetrahydropyridine derivative*its manufacture and therapeutical and preventive medicine containing said derivative for thrombosis or thromboangitis obliterans
DE2861211D1 (en) Imidazo(1,2-a)pyridine compounds, their preparation and anthelmintic compositions containing them

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JUNE 2001